BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10506931)

  • 1. Immunoreactivity of Thomsen-Friedenreich (TF) antigen in human neoplasms: the importance of carrier-specific glycotope expression on MUC1.
    Baldus SE; Hanisch FG; Monaca E; Karsten UR; Zirbes TK; Thiele J; Dienes HP
    Histol Histopathol; 1999 Oct; 14(4):1153-8. PubMed ID: 10506931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity of monoclonal antibody BW835 represents a marker of progression and prognosis in early gastric cancer.
    Baldus SE; Zirbes TK; Glossmann J; Fromm S; Hanisch FG; Mönig SP; Schröder W; Schneider PM; Flucke U; Karsten U; Thiele J; Hölscher AH; Dienes HP
    Oncology; 2001; 61(2):147-55. PubMed ID: 11528254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
    Hanisch FG; Stadie T; Bosslet K
    Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients.
    Baldus SE; Zirbes TK; Hanisch FG; Kunze D; Shafizadeh ST; Nolden S; Mönig SP; Schneider PM; Karsten U; Thiele J; Hölscher AH; Dienes HP
    Cancer; 2000 Apr; 88(7):1536-43. PubMed ID: 10738210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms.
    Baldus SE; Hanisch FG; Kotlarek GM; Zirbes TK; Thiele J; Isenberg J; Karsten UR; Devine PL; Dienes HP
    Cancer; 1998 Mar; 82(6):1019-27. PubMed ID: 9506345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope-dependent differential immunoreactivities of anti-MUC1 monoclonal antibodies in human carcinomas.
    Baldus SE; Goergen D; Hanisch FG; Dienes HP
    Int J Oncol; 2001 Mar; 18(3):507-12. PubMed ID: 11179479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
    Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
    Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma: an immunohistochemical analysis.
    Mylonas I; Mayr D; Walzel H; Shabani N; Dian D; Kuhn C; Kunze S; Jeschke U; Friese K
    Anticancer Res; 2007; 27(4A):1975-80. PubMed ID: 17649808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Thomsen-Friedenreich (TF) antigens on lymphocytes. I. Distribution of cryptic and exposed TF antigens on murine lymphocytes from different lymphoid organs: detection with an anti-TF monoclonal antibody and peanut agglutinin.
    Wolf MF; Schmitt HR; Schumacher K
    Cell Immunol; 1989 Jul; 121(2):360-5. PubMed ID: 2736629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epitope recognized by the unique anti-MUC1 monoclonal antibody MY.1E12 involves sialyl alpha 2-3galactosyl beta 1-3N-acetylgalactosaminide linked to a distinct threonine residue in the MUC1 tandem repeat.
    Takeuchi H; Kato K; Denda-Nagai K; Hanisch FG; Clausen H; Irimura T
    J Immunol Methods; 2002 Dec; 270(2):199-209. PubMed ID: 12379325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles.
    Wu X; McKay C; Pett C; Yu J; Schorlemer M; Ramadan S; Lang S; Behren S; Westerlind U; Finn MG; Huang X
    ACS Chem Biol; 2019 Oct; 14(10):2176-2184. PubMed ID: 31498587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Action of Thomsen-Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer.
    Peng Y; Zhan XX; Cao Y; Zhang HW; Cao WH; Su YJ; Diao C; Sun QM; Cheng RC
    Onco Targets Ther; 2020; 13():8677-8689. PubMed ID: 32982276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro.
    Jeschke U; Richter DU; Hammer A; Briese V; Friese K; Karsten U
    Histochem Cell Biol; 2002 Mar; 117(3):219-26. PubMed ID: 11914919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC1 glycoforms in breast cancer--cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation.
    Hanisch FG; Stadie TR; Deutzmann F; Peter-Katalinic J
    Eur J Biochem; 1996 Feb; 236(1):318-27. PubMed ID: 8617281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
    Saeland E; Belo AI; Mongera S; van Die I; Meijer GA; van Kooyk Y
    Int J Cancer; 2012 Jul; 131(1):117-28. PubMed ID: 21823122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential contributions of recognition factors of two plant lectins -Amaranthus caudatus lectin and Arachis hypogea agglutinin, reacting with Thomsen-Friedenreich disaccharide (Galbeta1-3GalNAcalpha1-Ser/Thr).
    Wu AM; Wu JH; Yang Z; Singh T; Goldstein IJ; Sharon N
    Biochimie; 2008; 90(11-12):1769-80. PubMed ID: 18809460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
    Deguchi T; Tanemura M; Miyoshi E; Nagano H; Machida T; Ohmura Y; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Ito T; Mori M; Doki Y; Sawa Y
    Cancer Res; 2010 Jul; 70(13):5259-69. PubMed ID: 20530670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TF-containing MUC1 glycopeptides fail to entice Galectin-1 recognition of tumor-associated Thomsen-Freidenreich (TF) antigen (CD176) in solution.
    FitzGerald FG; Rodriguez Benavente MC; Garcia C; Rivero Y; Singh Y; Wang H; Fields GB; Cudic M
    Glycoconj J; 2020 Dec; 37(6):657-666. PubMed ID: 33001366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.